For many years, treatment of multiple sclerosis (MS), as the most common, disabling neurological condition in young adults in the developed world has been hampered by a lack of understanding of its initiation and progression. However, accelerating progress in MS research on several fronts has ...
Current and Future Therapies for Multiple Sclerosis With the introduction of interferon-??1b in 1993 as the first FDA-approved treatment for multiple sclerosis, the era of treatment of this incurable disease... Minagar,Alireza - Scientifica,2013,(2013-2-7) 被引量: 95发表: 2013年 Taking agei...
Recent years have broadened the spectrum of therapeutic strategies and specific agents for treatment of multiple sclerosis (MS). While immune-modulating drugs remain the first-line agents for MS predominantly due to their benign safety profile, our growing understanding of key processes in initiation ...
Current treatment options for first-line immunotherapy in relapsing remitting multiple sclerosis are recombinant interferon-尾 and glatiramer acetate. Howe... Peter,Rieckmann - 《Journal of the Neurological Sciences》 被引量: 84发表: 2009年 Primary Progressive Multiple Sclerosis: Current and Future Trea...
Therapies for relapsing-remitting pediatric multiple sclerosis (MS) are aimed at preventing relapses (disease modifying therapies), treating acute attacks,
" writes Dr. Loredana La Mantia, Cochrane Multiple Sclerosis Cochrane and Rare Diseases of the Central Nervous System Group, Milan Italy, with coauthors. "The evaluation of the effectiveness of treatments for MS is complex, and identifying the most appropriate treatment for an individual patient ...
Multiple sclerosis, treatment, interferon beta, glatiramer acetate, natalizumab, cladribine, fingolimod, teriflunamide, rituximab, alemtuzumab, dimethyl fumarate, ocrelizumab, sphingosine 1 receptor modulation, laquinimod, daclizumabSince the first approved parenteral drug for the treatment of multiple ...
Ryan Haumschild, PharmD, MS, MBA: Now that we’ve talked about the background of multiple sclerosis [MS] in detail, I think it’s important for us to review the treatment landscape and the treatment paradigms for MS. Amanda, as we get started, I’d like for you to review some of ...
Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis Background: The current best practice suggests yearly magnetic resonance imaging (MRI) to monitor treatment response in multiple sclerosis (MS) patients. M Min,T Spelman,A Lugaresi,... - 《Multiple ...
An increasing number of children and adolescents with multiple sclerosis (MS) are being identified and treated with disease-modifying therapies. Yet, there